This Core resource to a program-project is focused on defining inborn protein defects that causeosteochondrodysplasia syndromes. We are determining the protein consequences at the molecular level ofmutations in genes that cause defects in cartilage structure. This Protein Biochemistry Core activelycollaborates in parallel with all projects by providing analytical data from specialized methods, includingprotein mass spectrometry, applied to tissue samples, purified proteins and cell-culture products. Bothluman material from the International Skeletal Dysplasias Registry and mouse tissue and cellular productsrom genetically engineered transgenic strains are being studied. Hypotheses as to the nature andbiochemical effects of mutations that cause abnormal skeletal development and adult function are integral tothe overall goals and aims of all projects and cores. The focus of the Protein Biochemistry Core is tounderstand the downstream molecular effects of mutations, both new ones identified by human genetic inkage and mutational analysis, and established mutations still with key questions on their proteinpathogenesis and created transgenic defects in mice. An example of the latter is the systemic collagendefect in crtap -/- mice.The clinical significance of core work includes direct benefits to families with the conditions under studythrough more specific diagnoses. In the long term, through an understanding of the effects of altered geneexpression, rational approaches to therapy are possible.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Program Projects (P01)
Project #
2P01HD022657-21A1
Application #
7245974
Study Section
Pediatrics Subcommittee (CHHD)
Project Start
2007-04-01
Project End
2012-03-31
Budget Start
2007-05-01
Budget End
2008-04-30
Support Year
21
Fiscal Year
2007
Total Cost
$172,770
Indirect Cost
Name
Cedars-Sinai Medical Center
Department
Type
DUNS #
075307785
City
Los Angeles
State
CA
Country
United States
Zip Code
90048
Joeng, Kyu Sang; Lee, Yi-Chien; Lim, Joohyun et al. (2017) Osteocyte-specific WNT1 regulates osteoblast function during bone homeostasis. J Clin Invest 127:2678-2688
Madan, Simran; Liu, Wei; Lu, James T et al. (2017) A non-mosaic PORCN mutation in a male with severe congenital anomalies overlapping focal dermal hypoplasia. Mol Genet Metab Rep 12:57-61
Rajagopal, Abbhirami; Homan, Erica P; Joeng, Kyu Sang et al. (2016) Restoration of the serum level of SERPINF1 does not correct the bone phenotype in Serpinf1 null mice. Mol Genet Metab 117:378-82
Xue, Yuan; Schoser, Benedikt; Rao, Aliz R et al. (2016) Exome Sequencing Identified a Splice Site Mutation in FHL1 that Causes Uruguay Syndrome, an X-Linked Disorder With Skeletal Muscle Hypertrophy and Premature Cardiac Death. Circ Cardiovasc Genet 9:130-5
Lietman, Caressa D; Marom, Ronit; Munivez, Elda et al. (2015) A transgenic mouse model of OI type V supports a neomorphic mechanism of the IFITM5 mutation. J Bone Miner Res 30:489-98
Hudson, David M; Joeng, Kyu Sang; Werther, Rachel et al. (2015) Post-translationally abnormal collagens of prolyl 3-hydroxylase-2 null mice offer a pathobiological mechanism for the high myopia linked to human LEPREL1 mutations. J Biol Chem 290:8613-22
Chen, Shan; Grover, Monica; Sibai, Tarek et al. (2015) Losartan increases bone mass and accelerates chondrocyte hypertrophy in developing skeleton. Mol Genet Metab 115:53-60
Ezgu, F; Krejci, P; Li, S et al. (2014) Phenotype-genotype correlations in patients with Marinesco-Sjögren syndrome. Clin Genet 86:74-84
Grafe, Ingo; Yang, Tao; Alexander, Stefanie et al. (2014) Excessive transforming growth factor-? signaling is a common mechanism in osteogenesis imperfecta. Nat Med 20:670-5
Homan, Erica P; Lietman, Caressa; Grafe, Ingo et al. (2014) Differential effects of collagen prolyl 3-hydroxylation on skeletal tissues. PLoS Genet 10:e1004121

Showing the most recent 10 out of 365 publications